[go: up one dir, main page]

IL182792A0 - Pharmaceutical compositions containing gepirone - Google Patents

Pharmaceutical compositions containing gepirone

Info

Publication number
IL182792A0
IL182792A0 IL182792A IL18279207A IL182792A0 IL 182792 A0 IL182792 A0 IL 182792A0 IL 182792 A IL182792 A IL 182792A IL 18279207 A IL18279207 A IL 18279207A IL 182792 A0 IL182792 A0 IL 182792A0
Authority
IL
Israel
Prior art keywords
gepirone
pharmaceutical compositions
compositions containing
pharmaceutical
containing gepirone
Prior art date
Application number
IL182792A
Original Assignee
Fabre Kramer Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Kramer Holdings Inc filed Critical Fabre Kramer Holdings Inc
Publication of IL182792A0 publication Critical patent/IL182792A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL182792A 2004-11-05 2007-04-26 Pharmaceutical compositions containing gepirone IL182792A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/032785 WO2006052227A1 (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Publications (1)

Publication Number Publication Date
IL182792A0 true IL182792A0 (en) 2007-08-19

Family

ID=36336794

Family Applications (1)

Application Number Title Priority Date Filing Date
IL182792A IL182792A0 (en) 2004-11-05 2007-04-26 Pharmaceutical compositions containing gepirone

Country Status (11)

Country Link
EP (1) EP1809255A4 (en)
JP (1) JP2008519071A (en)
CN (1) CN101076320A (en)
AU (1) AU2004324868B2 (en)
BR (1) BRPI0419179A (en)
CA (1) CA2585606A1 (en)
EA (1) EA013213B1 (en)
IL (1) IL182792A0 (en)
MX (1) MX2007005368A (en)
NO (1) NO20072851L (en)
WO (1) WO2006052227A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131906A1 (en) * 2013-11-18 2015-05-19 Gnosis Spa ORAL SOLID COMPOSITIONS WITH SLOW RELEASE
RU2713725C1 (en) * 2019-02-08 2020-02-06 Юрий Владимирович Соколов Biologically active additive and method of its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US6534507B1 (en) * 1999-12-20 2003-03-18 Fabre-Kramer Pharmaceuticals, Inc. Methods for treating psychological disorders using bioactive metabolites of gepirone
AU2002226371A1 (en) * 2000-12-08 2002-06-18 Akzo Nobel N.V. Oral extended release formulation of gepirone
US20030220346A1 (en) * 2000-12-18 2003-11-27 Kramer Stephen J. Use of bioactive metabolites of gepirone for the treatment of psychological disorders

Also Published As

Publication number Publication date
EP1809255A4 (en) 2011-08-03
JP2008519071A (en) 2008-06-05
EA013213B1 (en) 2010-04-30
AU2004324868A1 (en) 2006-05-18
EP1809255A1 (en) 2007-07-25
EA200701010A1 (en) 2007-10-26
MX2007005368A (en) 2007-09-11
CN101076320A (en) 2007-11-21
WO2006052227A1 (en) 2006-05-18
CA2585606A1 (en) 2006-05-18
AU2004324868B2 (en) 2010-04-29
BRPI0419179A (en) 2007-12-18
NO20072851L (en) 2007-07-31

Similar Documents

Publication Publication Date Title
IL238308B (en) Pharmaceutical compositions containing azelastine
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL177480A0 (en) Pharmaceutical composition
IL179933A0 (en) Pharmaceutical compositions containing proteosome based compositions
EP1729744A4 (en) Pharmaceutical formulations
IL183986A0 (en) Pharmaceutical compounds and compositions
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
EP1747004A4 (en) Pharmaceutical compositions for metabolic insufficiences
GB0405033D0 (en) Novel pharmaceutical compositions
GB0406378D0 (en) Novel pharmaceutical compositions
PL1837019T3 (en) Orally-dispersible pharmaceutical compositions
HU0401177D0 (en) Pharmaceutical composition
GB0406380D0 (en) Novel pharmaceutical compositions
PT2474528E (en) Antineoplasic compounds and pharmaceutical compositions thereof
GB2411355B (en) Pharmaceutical composition
GB0423800D0 (en) New pharmaceutical formulations
EP1805154A4 (en) Pharmaceutical compositions
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
IL182792A0 (en) Pharmaceutical compositions containing gepirone
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
GB0407351D0 (en) Pharmaceutical compositions